Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Cardiology

Genetics: Williams Syndrome vs. Isolated SVAS

At a Glance

Supravalvular Aortic Stenosis (SVAS) is caused by ELN gene changes, occurring either as Williams Syndrome or isolated SVAS. Williams Syndrome affects multiple body systems, while isolated SVAS usually causes more aggressive heart and blood vessel narrowing that may require earlier surgery.

Understanding the genetic cause of Supravalvular Aortic Stenosis (SVAS) is a vital step in managing long-term health. While the heart defect looks similar on an ultrasound, the underlying genetic “blueprint” determines whether the condition is isolated to the blood vessels or part of a broader syndrome that affects other parts of the body.

Two Paths: WBS vs. Isolated SVAS

Most cases of SVAS fall into one of two categories. Both involve the ELN gene, which provides instructions for making elastin, but the extent of the genetic change differs [1][2].

Williams-Beuren Syndrome (WBS)

WBS occurs when a small piece of Chromosome 7 (at a location called 7q11.23) is missing [3][4]. This missing piece, called a microdeletion, typically includes the ELN gene plus about 25 to 27 other neighboring genes [5].

  • The Multi-System Impact: Because other genes are missing (like BAZ1B), WBS affects more than just the heart. It can cause unique facial features, a highly social personality, developmental delays, and endocrine issues like hypercalcemia (high calcium levels) [6][7].
  • Vascular Pattern: Patients with WBS often have narrowing in both the aorta and the pulmonary arteries (the vessels leading to the lungs). While the aortic narrowing often needs surgery, the pulmonary narrowing sometimes improves on its own over time [8][9].

Isolated (Non-Syndromic) SVAS

In non-syndromic SVAS, the genetic change is focused primarily on the ELN gene itself, while the rest of the chromosome is intact [10][11].

  • Vascular Severity: Research suggests that patients with isolated SVAS may face a more “aggressive” vascular course. They often require earlier and more frequent surgeries for both the aorta and the aortic valve compared to those with WBS [12].
  • Family History: This form is more likely to be familial, meaning it can be passed down from a parent who may only have a mild, undiagnosed version of the condition [13][14].

Confirming the Diagnosis

Doctors use specialized tests to look at DNA. The order of testing matters:

  1. Chromosomal Microarray (CMA): This is often the first-choice test. It acts like a high-powered microscope that can see if the 7q11.23 region is missing (confirming WBS) [15][4].
  2. FISH Testing: An older but rapid test that uses fluorescent “probes” to see if a specific gene is missing. While effective for classic WBS, it can miss smaller, “atypical” deletions [16][17].
  3. ELN Gene Sequencing: If the microarray is normal but the patient has SVAS, doctors will perform a deep “spell-check” of the ELN gene itself to find tiny mutations that a microarray might miss [10][11].

Why the Distinction Matters

Knowing the genetic cause helps the care team prepare for the future.

  • Monitoring: A WBS diagnosis requires a multidisciplinary team including specialists in development, nutrition (for calcium management), and endocrinology [5][7].
  • Surgical Planning: In isolated SVAS, the surgical team may watch the aortic valve more closely, as it is more likely to be involved alongside the supravalvular narrowing [12].
  • Blood Pressure: Regardless of the genetic cause, both groups are at high risk for hypertension (high blood pressure) throughout their lives, requiring lifelong monitoring to protect the heart [18][19].

Common questions in this guide

What is the difference between Williams Syndrome and isolated SVAS?
Williams Syndrome is caused by a missing piece of chromosome 7 affecting multiple genes, leading to heart defects along with other systemic issues like high calcium levels. Isolated SVAS usually involves only the ELN gene, primarily affecting the blood vessels and heart without other developmental symptoms.
Which genetic tests are used to diagnose SVAS?
Doctors typically start with a Chromosomal Microarray (CMA) to check for the larger gene deletions seen in Williams Syndrome. If the microarray is normal, they may perform ELN gene sequencing to find smaller mutations that cause isolated SVAS.
Will I need more surgeries if I have isolated SVAS?
Research shows that patients with isolated SVAS often have a more aggressive vascular course. They may require earlier and more frequent surgeries for both the aorta and the aortic valve compared to those with Williams Syndrome.
Why do patients with Williams Syndrome need their calcium levels checked?
Because Williams Syndrome involves the deletion of multiple genes, it can cause endocrine issues like hypercalcemia, which is a high level of calcium in the blood. A specialized care team, including a nutritionist and endocrinologist, helps manage this symptom safely.
Do both forms of SVAS cause high blood pressure?
Yes, regardless of the underlying genetic cause, both Williams Syndrome and isolated SVAS place patients at a high risk for developing hypertension throughout their lives. Lifelong blood pressure monitoring is essential to protect long-term heart health.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was the genetic testing done using a full Microarray (CMA) or just a FISH test?
  2. 2.Based on the genetic results, should we be looking for other systemic issues like high calcium levels or narrowing in the kidney arteries?
  3. 3.Does this specific genetic result indicate a higher risk for needing more surgeries earlier in life compared to others with SVAS?
  4. 4.How do these genetic findings change the way we should monitor blood pressure long-term?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Novel ELN mutation in a Japanese family with a severe form of supravalvular aortic stenosis.

    Sugiyama K, Horigome H, Lin L, et al.

    Molecular genetics & genomic medicine 2019; (7(11)):e986 doi:10.1002/mgg3.986.

    PMID: 31560829
  2. 2

    Toward a rational therapeutic for elastin related disease: Key considerations for elastin based regenerative medicine strategies.

    Ganjibakhsh M, Tkachenko Y, Knutsen RH, Kozel BA

    Matrix biology : journal of the International Society for Matrix Biology 2025; (138()):8-21 doi:10.1016/j.matbio.2025.03.003.

    PMID: 40158781
  3. 3

    Clinical application of chromosomal microarray analysis for the diagnosis of Williams-Beuren syndrome in Chinese Han patients.

    Xia Y, Huang S, Wu Y, et al.

    Molecular genetics & genomic medicine 2019; (7(2)):e00517 doi:10.1002/mgg3.517.

    PMID: 30565396
  4. 4

    Health Care Supervision for Children With Williams Syndrome.

    Morris CA, Braddock SR,

    Pediatrics 2020; (145(2)) doi:10.1542/peds.2019-3761.

    PMID: 31964759
  5. 5

    Array CGH - A Powerful Tool in Molecular Diagnostic of Pathogenic Microdeletions - Williams-Beuren Syndrome - A Case Report.

    Streață I, Șerban-Șoșoi S, Budișteanu M, et al.

    Current health sciences journal 2016; (42(2)):207-212 doi:10.12865/CHSJ.42.02.14.

    PMID: 30568834
  6. 6

    Clinical Findings in a Series of Thirty Eight Patients with Williams-Beuren Syndrome.

    de Oliveira KMK, Simões LO, Dos Santos AM, Steiner CE

    Cytogenetic and genome research 2024; (164(3-4)):139-147 doi:10.1159/000540941.

    PMID: 39159616
  7. 7

    Dosage analysis of the 7q11.23 Williams region identifies BAZ1B as a major human gene patterning the modern human face and underlying self-domestication.

    Zanella M, Vitriolo A, Andirko A, et al.

    Science advances 2019; (5(12)):eaaw7908 doi:10.1126/sciadv.aaw7908.

    PMID: 31840056
  8. 8

    Long-term cardiovascular outcome of Williams syndrome.

    Cha SG, Song MK, Lee SY, et al.

    Congenital heart disease 2019; (14(5)):684-690 doi:10.1111/chd.12810.

    PMID: 31166070
  9. 9

    Long-Term Cardiovascular Findings in Williams Syndrome: A Single Medical Center Experience in Taiwan.

    Lee CL, Lin SM, Chen MR, et al.

    Journal of personalized medicine 2022; (12(5)) doi:10.3390/jpm12050817.

    PMID: 35629241
  10. 10

    [Genetic analysis of a child with atypical Williams-Beuren syndrome presenting as supravalvular aortic stenosis].

    Wu D, Zhang M, Gao Y, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(4)):475-478 doi:10.3760/cma.j.issn.1003-9406.2020.04.028.

    PMID: 32219841
  11. 11

    Novel ophthalmic findings and deep phenotyping in Williams-Beuren syndrome.

    Huryn LA, Flaherty T, Nolen R, et al.

    The British journal of ophthalmology 2023; (107(10)):1554-1559 doi:10.1136/bjophthalmol-2022-321103.

    PMID: 35760456
  12. 12

    Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy.

    Min S, Kinnear C, D'Alessandro LCA, et al.

    Circulation. Genomic and precision medicine 2020; (13(6)):e002971 doi:10.1161/CIRCGEN.120.002971.

    PMID: 32960096
  13. 13

    Frequent intragenic microdeletions of elastin in familial supravalvular aortic stenosis.

    Hayano S, Okuno Y, Tsutsumi M, et al.

    International journal of cardiology 2019; (274()):290-295 doi:10.1016/j.ijcard.2018.09.032.

    PMID: 30228022
  14. 14

    Novel ELN mutation in a family with supravalvular aortic stenosis and intracranial aneurysm.

    Jelsig AM, Urban Z, Hucthagowder V, et al.

    European journal of medical genetics 2017; (60(2)):110-113 doi:10.1016/j.ejmg.2016.11.004.

    PMID: 27866049
  15. 15

    Chromosomal Microarray Analysis in Taiwanese Patients with Williams-Beuren Syndrome.

    Kuo HT, Chen CH, Lin CY, et al.

    Cytogenetic and genome research 2019; (159(4)):182-189 doi:10.1159/000505282.

    PMID: 31931504
  16. 16

    Williams-Beuren Syndrome: A Clinical Study of 55 Brazilian Patients and the Diagnostic Use of MLPA.

    Honjo RS, Dutra RL, Furusawa EA, et al.

    BioMed research international 2015; (2015()):903175 doi:10.1155/2015/903175.

    PMID: 26090456
  17. 17

    An unusual combination of an atypical maternally inherited novel 0.3 Mb deletion in Williams-Beuren region and a de novo 22q11.21 microduplication in an infant with supravalvular aortic stenosis.

    Evangelidou P, Kousoulidou L, Salameh N, et al.

    European journal of medical genetics 2020; (63(12)):104084 doi:10.1016/j.ejmg.2020.104084.

    PMID: 33045407
  18. 18

    Chronic antihypertensive treatment improves pulse pressure but not large artery mechanics in a mouse model of congenital vascular stiffness.

    Halabi CM, Broekelmann TJ, Knutsen RH, et al.

    American journal of physiology. Heart and circulatory physiology 2015; (309(5)):H1008-16 doi:10.1152/ajpheart.00288.2015.

    PMID: 26232234
  19. 19

    Clinical Care for Cardiovascular Disease in Patients With Williams-Beuren Syndrome.

    Collins RT, Gravenhorst V, Faury G, et al.

    Journal of the American Heart Association 2024; (13(19)):e036997 doi:10.1161/JAHA.124.036997.

    PMID: 39291481

This page explains the genetic differences between Williams Syndrome and isolated SVAS for educational purposes. Always consult your genetic counselor or cardiologist for interpreting genetic test results and medical advice.

Get notified when new evidence is published on Supravalvular aortic stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.